Navigation Links
ASPIRE Phase III trial of vaginal ring to prevent HIV completes enrollment of 2,629 women
Date:6/26/2014

l beyond one year, the team determined a target enrollment of 2,600 participants would be sufficient to meet its objectives. Because the ASPIRE protocol was designed to accommodate new information as it becomes available, both the Study Monitoring Committee and the independent Data Safety and Monitoring Board (DSMB) that conducts routine reviews of the study were in agreement with the team. Indeed, at its most recent review on May 31, the DSMB recommended that the study, with 2,555 women enrolled to date, could stop screening new women and close enrollment soon thereafter.

When ASPIRE concludes in June or July 2015, all women will have used their assigned study product (placebo ring or dapivirine ring) for at least one year, a regulatory requirement, and some women will have used the ring two years or longer. (Because one of the main objectives of The Ring Study is to evaluate long-term safety of the ring, all women enrolled in that trial will use the monthly ring for two years.)

IPM will seek regulatory approval and licensure for the ring based on the results of The Ring Study and ASPIRE as well as several smaller safety studies taking place in the United States and Europe. A nonprofit product developer based in Silver Spring, Md., IPM is developing dapivirine for use as a vaginal microbicide in developing countries through a royalty-free licensing agreement with Janssen R&D Ireland.

Dapivirine, also known as TMC-120, belongs to a class of ARVs called non-nucleoside reverse transcriptase inhibitors (NNRTIs) that bind to and disable HIV's reverse transcriptase enzyme, a key protein needed for HIV replication. The dapivirine ring, made of a flexible silicone material, allows the drug to be slowly released from the ring over time. IPM's studies have shown that the ring can deliver dapivirine to vaginal tissue for a month or longer, with minimal concentration elsewhere in the body. Its studies to date have also shown that use of the dapivi
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-641-8940
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. MyPuress Announces Expansion into Canadian Market with Release of Aspiree Product Line
2. ALS patients differ on treatment choices in later phases of disease
3. Reach2HD, a Phase II study in Huntingtons disease, launched
4. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
5. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
6. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
7. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
8. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
9. Positive results from Phase 1/2 stem cell trial reported
10. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
11. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... (PRWEB) May 22, 2015 Family, friends, ... Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. Leffall, on ... The luncheon began after Grand Rounds in the hospital’s ... waited anxiously outside the auditorium, trying to keep the ... but if he sees me, he’ll know something is ...
(Date:5/22/2015)... R.I. (PRWEB) May 22, 2015 Memorial Day ... Amica Insurance is offering some tips to help ... Safety Council, there will be 383 traffic fatalities this Memorial ... from the National Highway Traffic Safety Association: , ... in the vehicle is wearing a seatbelt, whether they’re driving ...
(Date:5/22/2015)... 2015 Coco Libre, the Official Coconut Water ... Record at the 104th running of the race. On Sunday, ... served 315 people in one hour—one person about every 10 ... so true to the heart of the Bay Area, so ... luge to the finish line only made sense,” said Jennifer ...
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the ... now the 16th sweetFrog store located in the Lone Star ... on the Inc. 500 list of fastest growing companies in ... East Texas for 20 years and love the natural beauty ... and nearby Palestine, sweetFrog locations. “We are really excited about ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2
... By Serena Gordon HealthDay Reporter , FRIDAY, ... helped prevent or slow the progression of type 1 diabetes ... too early to say if the results might apply to ... the immune system,s response to newly developing diabetes, and reduced ...
... HealthDay Reporter , FRIDAY, May 11 (HealthDay News) ... health, reducing stress levels and contributing to better focus, a ... Irvine, and the U.S. Army found that a group of ... five days experienced more natural, variable heart rates and switched ...
... a concentrated, highly targeted dose of radiation to the ... area, with no adverse effects on survival and a ... the ten-year results of a randomised trial, Professor Csaba ... Institute of Oncology, Budapest, will tell the World Congress ...
... KU Leuven, succeeded in undoing the effect of one ... vitamin K2. His discovery gives hope to Parkinson,s patients. ... Northern Illinois University (US) and will be published this ... Science ., "It appears from our research that administering ...
... Denise Mann HealthDay Reporter , THURSDAY, May 10 ... marrow stem cells to enhance their healing potential may help ... small study suggests. Researchers developed the treatment by ... process helped increase the amount of immune cells and stem ...
... Inducing labor after a woman has been pregnant for more ... before, during or shortly after birth without increasing the need ... born after induced labor were also more likely to require ... led by Sarah Stock of the School of Women and ...
Cached Medicine News:Health News:Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says 2Health News:Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says 3Health News:'Email Vacations' Boost Job Productivity, Lower Stress: Study 2Health News:'Email Vacations' Boost Job Productivity, Lower Stress: Study 3Health News:Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer 2Health News:Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer 3Health News:Vitamin K2: New hope for Parkinson's patients? 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 3Health News:Induced Labor Late in Pregnancy Has Pros, Cons 2
(Date:5/22/2015)... Calif. , May 22, 2015 /PRNewswire/ ... the Company has commenced termination of its ... brodalumab with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... inhibitor, is in development for patients with ... spondyloarthritis.  The decision was based on events ...
(Date:5/22/2015)... ORLANDO, Fla. , May 22, 2015 ... Copay Assistance Program. This program provides financial assistance for ... "We are pleased to announce the addition of the ... programs," stated Mark McGreevy , executive director. "With ... mission and vision of a world where no one ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... Inc. (Nasdaq: MSON ), a developer of minimally ... used for the ablation of tumors and worldwide for ... first quarter ended September 30, 2009 financial results on ... President and Chief Executive Officer and Richard Zaremba, Senior ...
... Ind., Nov. 12 Zimmer Holdings, Inc. (NYSE: ZMH ... sell $1.0 billion of its senior unsecured notes in an ... due 2019 and $500.0 million of 5.75% notes due 2039. ... above their Treasury benchmark, and the 30-year notes were priced ...
Cached Medicine Technology:Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern 2Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes 2
This is an economical (portable) microtome designed for fast and accurate sectioning. The specimen rise is automatic and accurate with each handle movement. Section thickness from 5 to 40 microns. ...
Disposable Feather Blades, 50 per pack...
Fine abrasive for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Medicine Products: